Cargando…

[(11)C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy

OBJECTIVE: We tested whether in vivo neuroinflammation relates to the distinctive distributions of pathology in Alzheimer disease (AD) and progressive supranuclear palsy (PSP). METHODS: Sixteen patients with symptomatic AD (including amnestic mild cognitive impairment with amyloid-positive PET scan)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Passamonti, Luca, Rodríguez, Patricia Vázquez, Hong, Young T., Allinson, Kieren S.J., Bevan-Jones, W. Richard, Williamson, David, Jones, P. Simon, Arnold, Robert, Borchert, Robin J., Surendranathan, Ajenthan, Mak, Elijah, Su, Li, Fryer, Tim D., Aigbirhio, Franklin I., O'Brien, John T., Rowe, James B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980519/ https://www.ncbi.nlm.nih.gov/pubmed/29703774 http://dx.doi.org/10.1212/WNL.0000000000005610

Ejemplares similares

(18)F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
por: Passamonti, Luca, et al.
Publicado: (2017)

(11)C‐PK11195 PET imaging and white matter changes in Parkinson’s disease dementia
por: Nicastro, Nicolas, et al.
Publicado: (2019)

In Vivo (18)F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy
por: Malpetti, Maura, et al.
Publicado: (2022)

Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
por: Cope, Thomas E, et al.
Publicado: (2018)

Neuroinflammation predicts disease progression in progressive supranuclear palsy
por: Malpetti, Maura, et al.
Publicado: (2021)

Structural correlates of survival in Progressive Supranuclear Palsy
por: Street, Duncan, et al.
Publicado: (2023)

(18)F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy
por: Nicastro, Nicolas, et al.
Publicado: (2019)

Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses
por: Bevan-Jones, W Richard, et al.
Publicado: (2017)

Early microglial activation and peripheral inflammation in dementia with Lewy bodies
por: Surendranathan, Ajenthan, et al.
Publicado: (2018)

Correlation of microglial activation with white matter changes in dementia with Lewy bodies
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity
por: Kaalund, Sanne Simone, et al.
Publicado: (2020)

[(11)C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease
por: van den Ameele, Jelle, et al.
Publicado: (2021)

Validation of the new pathology staging system for progressive supranuclear palsy
por: Briggs, Mayen, et al.
Publicado: (2021)

Imaging tau burden in dementia with Lewy bodies using [(18)F]-AV1451 positron emission tomography
por: Mak, Elijah, et al.
Publicado: (2021)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

Speaker 1: John O’Brien, UK
por: O’Brien, John T, et al.
Publicado: (2016)

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
por: Mak, Elijah, et al.
Publicado: (2018)

Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2017)

[(18)F]-AV-1451 binding in the substantia nigra as a marker of neuromelanin in Lewy body diseases
por: Mak, Elijah, et al.
Publicado: (2021)

Altered structural connectivity networks in dementia with lewy bodies
por: Nicastro, Nicolas, et al.
Publicado: (2021)

[(18)F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
por: Bevan-Jones, W R, et al.
Publicado: (2018)

Neurophysiological consequences of synapse loss in progressive supranuclear palsy
por: Adams, Natalie E, et al.
Publicado: (2022)

Co‐Occurrence of Apathy and Impulsivity in Progressive Supranuclear Palsy
por: Kok, Zi Q., et al.
Publicado: (2021)

In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
por: Guedes, Carlos Eduardo Sampaio, et al.
Publicado: (2018)

Gray matter changes related to microglial activation in Alzheimer's disease
por: Nicastro, Nicolas, et al.
Publicado: (2020)

[(18)F]AV‐1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation
por: Bevan Jones, W. Richard, et al.
Publicado: (2016)

Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
por: Bevan-Jones, W Richard, et al.
Publicado: (2020)

Structural and Functional Thalamic Changes in Progressive Supranuclear Palsy
por: Tan, Sean YW, et al.
Publicado: (2022)

Progressive supranuclear palsy: diagnosis and management
por: Rowe, James B, et al.
Publicado: (2021)

Managing cognition in progressive supranuclear palsy
por: Rittman, Timothy, et al.
Publicado: (2016)

Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Jabbari, Edwin, et al.
Publicado: (2020)

Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisy.
por: da Silva, Marcelo Barreto Spillere, et al.
Publicado: (2004)

Abnormal neuroinflammation in fibromyalgia and CRPS using [(11)C]-(R)-PK11195 PET
por: Seo, Seongho, et al.
Publicado: (2021)

Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease
por: Malpetti, Maura, et al.
Publicado: (2020)

Altered network stability in progressive supranuclear palsy
por: Whiteside, David J, et al.
Publicado: (2021)

Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants
por: Street, Duncan, et al.
Publicado: (2021)

Neuroinflammatory and morphological changes in late-life depression: the NIMROD study
por: Su, L., et al.
Publicado: (2016)

The protective effect of PK11195 on D-galactose-induced amnestic mild cognitive impairment in rats
por: Ye, Chen, et al.
Publicado: (2020)

Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia
por: Malpetti, Maura, et al.
Publicado: (2023)

Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
por: Chouliaras, Leonidas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0gpqkks1idms49uf4lc9huo7ks